Preparticipation Screening of Athletes: The Prevalence of Positive Family History

被引:4
作者
Jiravska Godula, Bogna [1 ,2 ]
Jiravsky, Otakar [2 ,3 ]
Pesova, Petra [1 ,2 ]
Jelinek, Libor [1 ]
Sovova, Marketa [1 ]
Moravcova, Katarina [1 ]
Ozana, Jaromir [1 ]
Hudec, Miroslav [2 ,3 ]
Miklik, Roman [2 ,3 ]
Hecko, Jan [2 ,4 ]
Sknouril, Libor [2 ]
Sovova, Eliska [1 ]
机构
[1] Palacky Univ, Fac Med, Krizkovskeho 511 8, Olomouc 77900, Czech Republic
[2] Nemocnice Agel Trinec Podlesi, Sports Cardiol Ctr, Konska 453, Trinec 73961, Czech Republic
[3] Masaryk Univ, Fac Med, Kamenice 735 5, Brno 62500, Czech Republic
[4] VSB Tech Univ Ostrava, Fac Elect Engn & Comp Sci, Ostrava 70833, Czech Republic
关键词
sudden cardiac death; athlete; preparticipation screening; SUDDEN CARDIAC DEATH; PHYSICAL-ACTIVITY; IMPLEMENTATION; HEART; RISK;
D O I
10.3390/jcdd10040183
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Sudden cardiac death (SCD) is a leading cause of death among athletes, and those with a positive family history (FH) of SCD and/or cardiovascular disease (CVD) may be at increased risk. The primary objective of this study was to assess the prevalence and predictors of positive FH of SCD and CVD in athletes using four widely used preparticipation screening (PPS) systems. The secondary objective was to compare the functionality of the screening systems. In a cohort of 13,876 athletes, 1.28% had a positive FH in at least one PPS system. Multivariate logistic regression analysis identified the maximum heart rate as significantly associated with positive FH (OR = 1.042, 95% CI = 1.027-1.056, p < 0.001). The highest prevalence of positive FH was found using the PPE-4 system (1.20%), followed by FIFA, AHA, and IOC systems (1.11%, 0.89%, and 0.71%, respectively). In conclusion, the prevalence of positive FH for SCD and CVD in Czech athletes was found to be 1.28%. Furthermore, positive FH was associated with a higher maximum heart rate at the peak of the exercise test. The findings of this study revealed significant differences in detection rates between PPS protocols, so further research is needed to determine the optimal method of FH collection.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Preparticipation Screening of Competitive Athletes Seeking Simple Solutions to a Complex Problem
    Thompson, Paul D.
    CIRCULATION, 2009, 119 (08) : 1072 - 1074
  • [22] Significance of False Negative Electrocardiograms in Preparticipation Screening of Athletes for Hypertrophic Cardiomyopathy
    Rowin, Ethan J.
    Maron, Barry J.
    Appelbaum, Evan
    Link, Mark S.
    Gibson, C. Michael
    Lesser, John R.
    Haas, Tammy S.
    Udelson, James E.
    Manning, Warren J.
    Maron, Martin S.
    AMERICAN JOURNAL OF CARDIOLOGY, 2012, 110 (07) : 1027 - 1032
  • [23] ECG diagnostics in competitive athletes. Current implications for preparticipation screening
    Pressler, A.
    Halle, M.
    HERZ, 2012, 37 (05) : 474 - 484
  • [24] Can we prevent sudden cardiac death in young athletes: the debate about preparticipation sports screening
    Patel, Angira
    Lantos, John D.
    ACTA PAEDIATRICA, 2011, 100 (10) : 1297 - 1301
  • [25] Preparticipation screening and prevention of sudden cardiac death in athletes: Implications for primary care
    Morse, Emily
    Funk, Marjorie
    JOURNAL OF THE AMERICAN ACADEMY OF NURSE PRACTITIONERS, 2012, 24 (02): : 63 - 69
  • [26] Preparticipation screening—the way forward is smart screening
    H. Thune Jørstad
    Netherlands Heart Journal, 2018, 26 : 120 - 122
  • [27] The Validity of Adding ECG to the Preparticipation Screening of Athletes An Evidence Based Literature Review
    Alattar, A.
    Maffulli, N.
    TRANSLATIONAL MEDICINE AT UNISA, 2015, 11 : 2 - 13
  • [28] Accuracy of ECG-inclusive preparticipation screening in athletes: more work to be done
    Weiner, Rory B.
    Baggish, Aaron L.
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2012, 10 (06) : 671 - 673
  • [29] Who Should Interpret Screening Preparticipation ECGs in Young Athletes?
    Alexander Hutchinson
    Nicolas K. Goff
    Nicole Cain
    Peter N. Dean
    Deepak Kamat
    Lanier Jackson
    Current Treatment Options in Cardiovascular Medicine, 2023, 25 : 851 - 864
  • [30] Preparticipation screening-the way forward is smart screening
    Jorstad, H. Thune
    NETHERLANDS HEART JOURNAL, 2018, 26 (03) : 120 - 122